2022 Open houses, hosted at Biotrial’s Phase I Facilities in New Jersey
Biotrial was pleased to invite sponsors to Open-Houses in June and November to its state-of-the-art Clinical Pharmacology Unit in Newark, NJ.
This Open House was an exciting opportunity to discover Biotrial’s Phase I unit and engage with early development experts Nicolas Fauchoux, Chief Operating Officer, and Phil Davies, President of Biotrial North America and Head of Global Scientific & Strategic Affairs.
Throughout the day, the sponsors had multiple tours of the facilities, allowing them to see first-hand the cutting-edge technology and equipment used to conduct clinical trials and to speak with Biotrial’s knowledgeable staff. Our Core Lab team presented 3 workshops dedicated in EEG and shared their expertise during the workshops.
With over 30 years of experience and a proven track record of success, Biotrial is a trusted partner for early-phase clinical research. The company’s Clinical Pharmacology Unit in Newark, NJ, is a state-of-the-art facility that provides an exceptional environment for conducting clinical trials. From the latest equipment and technology to the highly trained and experienced staff, everything at Biotrial is designed to ensure the highest level of quality and safety for all participants.
